Pura Vida Investments’s Evolent Health EVH Stock Holding History

Pura Vida Investments’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-64,573	Closed	-$2.13M	–	58
2023 Q4	$2.13M	Buy	+64,573	New	+$1.83M	0.33%	36
2023 Q3	–	Sell	-39,397	Closed	-$1.19M	–	94
2023 Q2	$1.19M	Sell	39,397 -143,480	-78%	-$4.64M	0.16%	72
2023 Q1	$5.93M	Buy	182,877 +66,677	+57%	+$2.11M	0.6%	45
2022 Q4	$3.26M	Buy	+116,200	New	+$3.33M	0.17%	105
2022 Q3	–	Sell	-230,000	Closed	-$7.06M	–	218
2022 Q2	$7.06M	Buy	230,000 +30,000	+15%	+$874K	0.41%	65
2022 Q1	$6.46M	Buy	+200,000	New	+$5.24M	0.21%	105
2021 Q4	–	Sell	-275,000	Closed	-$8.53M	–	260
2021 Q3	$8.53M	Buy	+275,000	New	+$6.6M	0.26%	107

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Pura Vida Investments's EVH Position: Q1 2024 in Review

Pura Vida Investments sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 64,573 shares — an estimated $2.13M sold.

Pura Vida Investments first reported a position in EVH in Q3 2021 and held it in 7 quarters. The position peaked at $8.53M in Q3 2021. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

Pura Vida Investments reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
Pura Vida Investments sold 64,573 Evolent Health shares in Q1 2024, an estimated $2.13M.
Pura Vida Investments first reported a position in Evolent Health in Q3 2021 and held it in 7 quarters.
Pura Vida Investments's Evolent Health position peaked at $8.53M in Q3 2021.
251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.